C14ORF119 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.157800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.961800E-01
Normal-vs-Stage2
4.478000E-01
Normal-vs-Stage3
7.346400E-01
Normal-vs-Stage4
3.349200E-01
Stage1-vs-Stage2
3.928000E-01
Stage1-vs-Stage3
6.112600E-01
Stage1-vs-Stage4
2.189000E-01
Stage2-vs-Stage3
1.402790E-01
Stage2-vs-Stage4
4.367400E-01
Stage3-vs-Stage4
2.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.444400E-01
Normal-vs-AfricanAmerican
7.256400E-01
Normal-vs-Asian
2.810400E-01
Caucasian-vs-AfricanAmerican
9.168800E-01
Caucasian-vs-Asian
5.883200E-01
AfricanAmerican-vs-Asian
6.830800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.442000E-01
Normal-vs-Female
5.007600E-01
Male-vs-Female
5.718200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.279000E-01
Normal-vs-Age(41-60Yrs)
2.621800E-01
Normal-vs-Age(61-80Yrs)
7.061000E-01
Normal-vs-Age(81-100Yrs)
9.042400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.132600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.467200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.376000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.968000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.021200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.764400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.751200E-01
Normal-vs-Daily Drinker
6.959400E-01
Normal-vs-Weekly Drinker
6.109800E-01
Normal-vs-Occasional Drinker
2.312400E-01
Normal-vs-Social Drinker
2.021200E-01
Non Drinker-vs-Daily Drinker
6.405800E-01
Non Drinker-vs-Weekly Drinker
5.554800E-01
Non Drinker-vs-Occasional Drinker
9.189500E-02
Non Drinker-vs-Social Drinker
2.122800E-01
Daily Drinker-vs-Weekly Drinker
8.583000E-01
Daily Drinker-vs-Occasional Drinker
2.221400E-01
Daily Drinker-vs-Social Drinker
5.351000E-01
Weekly Drinker-vs-Occasional Drinker
3.365600E-01
Weekly Drinker-vs-Social Drinker
7.422600E-01
Occasional Drinker-vs-Social Drinker
3.605800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.707400E-01
Normal-vs-Grade 2
8.847000E-01
Normal-vs-Grade 3
8.654000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.438200E-03
Grade 1-vs-Grade 3
8.324100E-03
Grade 1-vs-Grade 4
9.707400E-01
Grade 2-vs-Grade 3
6.504600E-01
Grade 2-vs-Grade 4
8.847000E-01
Grade 3-vs-Grade 4
8.654000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.190400E-01
Normal-vs-NonDiabetic
5.248400E-01
Diabetic-vs-NonDiabetic
9.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.937800E-01
Normal-vs-NoPancreatitis
5.395200E-01
Pancreatitis-vs-NoPancreatitis
6.653400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.335800E-01
Normal-vs-N1
4.817600E-01
N0-vs-N1
7.075000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.475400E-01
Normal-vs-TP53-NonMutant
9.136200E-01
TP53-Mutant-vs-TP53-NonMutant
1.6168900000002E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
